We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Alibaba
BABA
$308B
| $1.31M | 0.01% |
16,064
-21,009
| -57% | -$1.65M |
|
652
Affiliated Managers Group
AMG
$9.76B
| $1.29M | 0.01% |
+8,084
| New | +$1.39M |
|
653
Boise Cascade
BCC
$3.02B
| $1.29M | 0.01% |
+50,460
| New | +$1.44M |
|
|
EXAM
654
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $1.27M | 0.01% |
+47,878
| New | +$1.29M |
|
|
VISN
655
Vistance Networks Inc
VISN
$2.52B
| $1.27M | 0.01% |
48,916
-29,908
| -38% | -$861K |
|
|
AGRX
656
DELISTED
Agile Therapeutics
AGRX
| $1.27M | 0.01% |
65
+3
| +5% | +$47.5K |
|
657
Standard Motor Products
SMP
$911M
| $1.27M | 0.01% |
+33,278
| New | +$1.33M |
|
|
WLL
658
DELISTED
Whiting Petroleum Corporation
WLL
| $1.27M | 0.01% |
447
+278
| +164% | +$1.32M |
|
|
GWR
659
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.26M | 0.01% |
+23,413
| New | +$1.48M |
|
660
TransUnion
TRU
$15.3B
| $1.25M | 0.01% |
45,285
-77,540
| -63% | -$1.99M |
|
|
ITCI
661
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.25M | 0.01% |
23,148
+4,410
| +24% | +$222K |
|
|
AZPN
662
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $1.24M | 0.01% |
32,940
+25,040
| +317% | +$946K |
|
663
AeroVironment
AVAV
$9.45B
| $1.24M | 0.01% |
+41,900
| New | +$1.03M |
|
|
LPT
664
DELISTED
Liberty Property Trust
LPT
| $1.24M | 0.01% |
+39,787
| New | +$1.32M |
|
665
Masco
MAS
$15.3B
| $1.23M | 0.01% |
43,498
-79,181
| -65% | -$2.25M |
|
666
MaxLinear
MXL
$6.8B
| $1.22M | 0.01% |
+82,691
| New | +$1.24M |
|
667
Cooper-Standard Automotive
CPS
$558M
| $1.21M | 0.01% |
+15,610
| New | +$1.1M |
|
|
FINL
668
DELISTED
Finish Line
FINL
| $1.2M | 0.01% |
+66,434
| New | +$1.18M |
|
669
Central Pacific Financial
CPF
$1B
| $1.2M | 0.01% |
54,290
-237,025
| -81% | -$5.25M |
|
670
HDFC Bank
HDB
$121B
| $1.19M | 0.01% |
77,356
-26,152
| -25% | -$395K |
|
671
Textron
TXT
$15.4B
| $1.19M | 0.01% |
+28,298
| New | +$1.17M |
|
672
CNA Financial
CNA
$14.1B
| $1.19M | 0.01% |
+33,780
| New | +$1.21M |
|
673
Charles River Laboratories
CRL
$12.8B
| $1.18M | 0.01% |
14,638
-18,833
| -56% | -$1.36M |
|
674
Moog Inc Class A
MOG.A
$12.8B
| $1.17M | 0.01% |
19,352
+14,952
| +340% | +$927K |
|
|
AET
675
DELISTED
Aetna Inc
AET
| $1.16M | 0.01% |
10,758
-256,046
| -96% | -$27.7M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.